• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Sarizotan - Articles and news items

Newron receives go ahead to test Sarizotan for treatment of Rett Syndrome

Newron receives go ahead to test Sarizotan for treatment of Rett Syndrome

Industry news / 18 May 2016 / Mandy Parrett, Editorial Assistant

Biopharmaceutical company, Newron, has announced that its Investigational New Drug (IND) application to evaluate Sarizotan in treatment of Rett Syndrome has been approved by the FDA.

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionWATCH NOW
+ +